Discontinued — last reported Q4 '23
Medtronic Other — Net Sales decreased by 22.7% to $17.00M in Q4 2023 compared to the prior quarter. Year-over-year, this metric declined by 79.0%, from $81.00M to $17.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful scaling of emerging business lines or new product adoption, while a decrease may indicate divestitures or the maturation of non-core assets.
This metric represents the total revenue generated from business units or product lines that do not fall into the compan...
Peers often report this as 'Other,' 'Corporate,' or 'Emerging Business' revenue, which typically represents a smaller, non-core portion of total consolidated sales.
mdt_segment_other_net_sales| Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|
| Value | $81.00M | $82.00M | $81.00M | $16.00M | $22.00M | $17.00M |
| QoQ Change | — | +1.2% | -1.2% | -80.2% | +37.5% | -22.7% |
| YoY Change | — | — | — | -80.2% | -73.2% | -79.0% |